Report cover image

U.S. Allergy and Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Products & Services (Allergy Diagnostics, Autoimmune Disease Diagnostics), By Test Type, By Diagnostics Type, By End Use – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Aug 01, 2025
Length 128 Pages
SKU # PLRS20381605

Description

The U.S. allergy and autoimmune disease diagnostics market size is expected to reach USD 9.56 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Allergy and Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Products & Services (Allergy Diagnostics, Autoimmune Disease Diagnostics), By Test Type, By Diagnostics Type, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. market for allergy and autoimmune disease diagnostics involves a range of tests and services. These are designed to identify and monitor conditions where the immune system is not working correctly. This includes allergies, which are an overreaction to harmless things in the environment, and autoimmune diseases, where the immune system attacks the body's own healthy tissues. The products in this market can be as simple as blood tests or as advanced as genetic sequencing.

The U.S. allergy and autoimmune disease diagnostics market is highly competitive. Companies are trying to create more accurate and effective diagnostic tools. The goal is to provide fast and reliable results that help doctors make the right decisions about a patient's care. The overall market is seeing growth owing to the high prevalence of these conditions, a greater focus on early diagnosis, and ongoing improvements in testing technology.

Have

U.S. Allergy and Autoimmune Disease Diagnostics Market Report Highlights:

Based on product & services, the allergy diagnostics segment held the largest share in 2024. due to the increasing prevalence of conditions such as asthma, allergic rhinitis, and food allergies.

Based on test type, the allergy diagnostics segment held the largest share in 2024. due to the wide use of diagnostic tests that identify common allergens.

Based on diagnostics type, the allergy diagnostics segment held the largest share in 2024, as there is a rise in public awareness and a growing requirement for allergy identification.

Based on end use, the allergy diagnostics segment held the largest share in 2024, due to their large patient volumes and access to advanced equipment.

A few key players in the U.S. allergy and autoimmune disease diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Quest Diagnostics, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific (Phadia AB), and Grifols S.A. Other companies like bioMérieux SA, Trinity Biotech plc, Werfen, and EUROIMMUN Medizinische Labordiagnostika AG.

Polaris Market Research has segmented the U.S. allergy and autoimmune disease diagnostics market report based on products & services, test type, diagnostics type, and end use:

By Products & Services Outlook (Revenue – USD Billion, 2020–2034)

Allergy Diagnostics

Instruments

Consumables

Services

Autoimmune Disease Diagnostics

Instruments

Consumables

Services

By Test Type Outlook (Revenue – USD Billion, 2020–2034)

Allergy Diagnostics

In vivo Test

Skin Prick Test

Intradermal Test

Patch Test

In vitro Test

Autoimmune Disease Diagnostics

Antinuclear Antibody Tests

Autoantibody Tests

C-reactive Protein (CRP)

Complete Blood Count (CBC)

Urinalysis

Others

By Diagnostics Type Outlook (Revenue – USD Billion, 2020–2034)

Allergy Diagnostics

Food

Dairy Products

Poultry Product

Tree Nuts

Peanuts

Shellfish

Wheat

Soys

Other Food Allergens

Inhaled

Drug

Other Allergens

Autoimmune Disease Diagnostics

Systemic Autoimmune Disease Diagnostics

Rheumatoid Arthritis

Ankylosing Spondylitis

Systemic Lupus Erythematosus (SLE)

Others

Localized Autoimmune Disease Diagnostics

Multiple Sclerosis

Type 1 Diabetes

Hashimoto's Thyroiditis

Idiopathic Thrombocytopenic Purpura

Others

By End Use Outlook (Revenue – USD Billion, 2020–2034)

Allergy Diagnostics

Hospitals & Clinics

Diagnostics Laboratories

Research Institutions

Others

Autoimmune Disease

Hospitals & Clinics

Diagnostics Laboratories

Research Institutions

Others

Table of Contents

128 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Allergy and Autoimmune Disease Diagnostics Market Insights
4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market – Market Snapshot
4.2. U.S. Allergy and Autoimmune Disease Diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Prevalence of Allergic and Autoimmune Diseases
4.2.1.2. Technological Advancements in Diagnostics
4.2.2. Restraints and Challenges
4.2.2.1. High cost of diagnostic tests and limited reimbursement
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Allergy and Autoimmune Disease Diagnostics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services, 2020–2034 (USD Billion)
5.3. Allergy Diagnostics
5.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020–2034 (USD Billion)
5.3.2. Instruments
5.3.3. Consumables
5.3.4. Services
5.4. Autoimmune Disease Diagnostics
5.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020–2034 (USD Billion)
5.4.2. Instruments
5.4.3. Consumables
5.4.4. Services
6. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2020–2034 (USD Billion)
6.3. Allergy Diagnostics
6.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020–2034 (USD Billion)
6.3.2. In vivo Test
6.3.2.1. Skin Prick Test
6.3.2.2. Intradermal Test
6.3.2.3. Patch Test
6.3.3. In vitro Test
6.4. Autoimmune Disease Diagnostics
6.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020–2034 (USD Billion)
6.4.2. Antinuclear Antibody Tests
6.4.3. Autoantibody Tests
6.4.4. C-reactive Protein (CRP)
6.4.5. Complete Blood Count (CBC)
6.4.6. Urinalysis
6.4.7. Others
7. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2020–2034 (USD Billion)
7.3. Allergy Diagnostics
7.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020–2034 (USD Billion)
7.3.2. Food
7.3.2.1. Dairy Products
7.3.2.2. Poultry Product
7.3.2.3. Tree Nuts
7.3.2.4. Peanuts
7.3.2.5. Shellfish
7.3.2.6. Wheat
7.3.2.7. Soys
7.3.2.8. Other Food Allergens
7.3.3. Inhaled
7.3.4. Drug
7.3.5. Other Allergens
7.4. Autoimmune Disease Diagnostics
7.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020–2034 (USD Billion)
7.4.2. Systemic Autoimmune Disease Diagnostics
7.4.2.1. Rheumatoid Arthritis
7.4.2.2. Ankylosing Spondylitis
7.4.2.3. Systemic Lupus Erythematosus (SLE)
7.4.2.4. Others
7.4.3. Localized Autoimmune Disease Diagnostics
7.4.3.1. Multiple Sclerosis
7.4.3.2. Type 1 Diabetes
7.4.3.3. Hashimoto's Thyroiditis
7.4.3.4. Idiopathic Thrombocytopenic Purpura
7.4.3.5. Others
8. U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use, 2020–2034 (USD Billion)
8.3. Allergy Diagnostics
8.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020–2034 (USD Billion)
8.3.2. Hospitals & Clinics
8.3.3. Diagnostics Laboratories
8.3.4. Research Institutions
8.3.5. Others
8.4. Autoimmune Disease
8.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease, by Region, 2020–2034 (USD Billion)
8.4.2. Hospitals & Clinics
8.4.3. Diagnostics Laboratories
8.4.4. Research Institutions
8.4.5. Others
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Bio-Rad Laboratories
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. bioMérieux SA
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. EUROIMMUN Medizinische Labordiagnostika AG (Revvity, Inc.)
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Grifols S.A.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Quest Diagnostics
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Siemens Healthineers AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Thermo Fisher Scientific Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Trinity Biotech plc
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Werfen
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us